Walter Stühmer

Walter Stühmer

Auto-generated profile, based on publicly available information

Walter Stühmer

Instituto Max-Planck para Medicina Experimental, Göttingen, Alemania

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2006 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
BHBernhard Hemmerlein
Bernhard Hemmerlein
RWRüdiger M Weseloh
Rüdiger M Weseloh
FQFernanda Mello de Queiroz
Fernanda Mello de Queiroz
HKHendrik Knötgen
Hendrik Knötgen
ASAraceli Sánchez
Araceli Sánchez
Luis PardoLuis Pardo
Luis Pardo
Background: Certain types of potassium channels (known as Eag1, KCNH1, Kv10.1) are associated with the production of tumours in patients and in animals. We have now studied the expression pattern of the Eag1 channel in a large range of normal and tumour tissues from different collections utilising molecular biological and immunohistochemical techniques. Results: The use of reverse transcription real-time PCR and specifically generated monoclonal anti-Eag1 antibodies showed that expression of the channel is normally limited to specific areas of the brain and to restricted cell populations throughout the body. Tumour samples, however, showed a significant overexpression of the channel with high frequency (up to 80% depending on the tissue source) regardless of the detection method (staining with either one of the antibodies, or detection of Eag1 RNA). Conclusion: Inhibition of Eag1 expression in tumour cell lines reduced cell proliferation. Eag1 may therefore represent a promising target for the tailored treatment of human tumours. Furthermore, as normal cells expressing Eag1 are either protected by the blood-brain barrier or represent the terminal stage of normal differentiation, Eag1 based therapies could produce only minor side effects.

17 April 2013 in Glia
Verified
Journal Article
Closed access
PDF file
MLMarcio Lazzarini
Marcio Lazzarini
SMSabine Martin
Sabine Martin
MMMišo Mitkovski
Mišo Mitkovski
RVRita Raisman Vozari
Rita Raisman Vozari
WSWalter Stühmer
Walter Stühmer
EDElaine Del-Bel
Elaine Del-Bel

27 January 2010 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
JAJasmin R Agarwal
Jasmin R Agarwal
FGFrank - Griesinger
Frank - Griesinger
WSWalter Stühmer
Walter Stühmer
Luis PardoLuis Pardo
Luis Pardo
Background: The voltage-gated potassium channel hEag1 (KV10.1) has been related to cancer biology. The physiological expression of the human channel is restricted to the brain but it is frequently and abundantly expressed in many solid tumors, thereby making it a promising target for a specific diagnosis and therapy. Because chronic lymphatic leukemia has been described not to express hEag1, it has been assumed that the channel is not expressed in hematopoietic neoplasms in general.Results: Here we show that this assumption is not correct, because the channel is up-regulated in myelodysplastic syndromes, chronic myeloid leukemia and almost half of the tested acute myeloid leukemias in a subtype-dependent fashion. Most interestingly, channel expression strongly correlated with increasing age, higher relapse rates and a significantly shorter overall survival. Multivariate Cox regression analysis revealed hEag1 expression levels in AML as an independent predictive factor for reduced disease-free and overall survival; such an association had not been reported before. As a functional correlate, specific hEag1 blockade inhibited the proliferation and migration of several AML cell lines and primary cultured AML cellsin vitro.Conclusion: Our observations implicate hEag1 as novel target for diagnostic, prognostic and/or therapeutic approaches in AML.

5 October 2006 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
FQFernanda Mello de Queiroz
Fernanda Mello de Queiroz
GSGuilherme Suarez-Kurtz
Guilherme Suarez-Kurtz
WSWalter Stühmer
Walter Stühmer
Luis PardoLuis Pardo
Luis Pardo
Background: The expression of the human Eag1 potassium channel (Kv10.1) is normally restricted to the adult brain, but it has been detected in both tumour cell lines and primary tumours. Our purpose was to determine the frequency of expression of Eag1 in soft tissue sarcoma and its potential clinical implications. Results: We used specific monoclonal antibodies to determine the expression levels of Eag1 in soft tissue sarcomas from 210 patients by immunohistochemistry. Eag1 was expressed in 71% of all tumours, with frequencies ranging from 56% (liposarcoma) to 82% (rhabdomyosarcoma). We detected differences in expression levels depending on the histological type, but no association was seen between expression of this protein and sex, age, grade or tumour size. Four cell lines derived from relevant sarcoma histological types (fibrosarcoma and rhabdomyosarcoma) were tested for Eag1 expression by real-time RT-PCR. We found all four lines to be positive for Eag1. In these cell lines, blockage of Eag1 by RNA interference led to a decrease in proliferation. Conclusion: Eag1 is aberrantly expressed in over 70% sarcomas. In sarcoma cell lines, inhibition of Eag1 expression and/or function leads to reduced proliferation. The high frequency of expression of Eag1 in primary tumours and the restriction of normal expression of the channel to the brain, suggests the application of this protein for diagnostic or therapeutic purposes.

24 March 2011 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
SGSabrina Grube
Sabrina Grube
MGMartin F. Gerchen
Martin F. Gerchen
BABartosz Adamcio
Bartosz Adamcio
Luis PardoLuis Pardo
Luis Pardo
SMSabine Martin
Sabine Martin
HEHannelore Ehrenreich
Hannelore Ehrenreich
KCNN3, encoding the small conductance calcium‐activated potassium channel SK3, harbours a polymorphic CAG repeat in the amino‐terminal coding region with yet unproven function. Hypothesizing that KCNN3 genotypes do not influence susceptibility to schizophrenia but modify its phenotype, we explored their contribution to specific schizophrenic symptoms. Using the Göttingen Research Association for Schizophrenia (GRAS) data collection of schizophrenic patients (n = 1074), we performed a phenotype‐based genetic association study (PGAS) of KCNN3. We show that long CAG repeats in the schizophrenic sample are specifically associated with better performance in higher cognitive tasks, comprising the capacity to discriminate, select and execute (p < 0.0001). Long repeats reduce SK3 channel function, as we demonstrate by patch‐clamping of transfected HEK293 cells. In contrast, modelling the opposite in mice, i.e. KCNN3 overexpression/channel hyperfunction, leads to selective deficits in higher brain functions comparable to those influenced by SK3 conductance in humans. To conclude, KCNN3 genotypes modify cognitive performance, shown here in a large sample of schizophrenic patients. Reduction of SK3 function may constitute a pharmacological target to improve cognition in schizophrenia and other conditions with cognitive impairment. →See accompanying Closeup by Anil K Malhotra http://dx.doi.org/10.1002/emmm.201100137

3 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYe Chen
Ye Chen
ASAraceli Sánchez
Araceli Sánchez
MRMaría E. Rubio
María E. Rubio
TKTobias Kohl
Tobias Kohl
Luis PardoLuis Pardo
Luis Pardo
WSWalter Stühmer
Walter Stühmer
Ectopically expressed human KV10.1 channels are relevant players in tumor biology. However, their function as ion channels at the plasma membrane does not totally explain their crucial role in tumors. Both in native and heterologous systems, it has been observed that a majority of KV10.1 channels remain at intracellular locations. In this study we investigated the localization and possible roles of perinuclear KV10.1. We show that KV10.1 is expressed at the inner nuclear membrane in both human and rat models; it co-purifies with established inner nuclear membrane markers, shows resistance to detergent extraction and restricted mobility, all of them typical features of proteins at the inner nuclear membrane. KV10.1 channels at the inner nuclear membrane are not all transported directly from the ER but rather have been exposed to the extracellular milieu. Patch clamp experiments on nuclei devoid of external nuclear membrane reveal the existence of channel activity compatible with KV10.1. We hypothesize that KV10.1 channels at the nuclear envelope might participate in the homeostasis of nuclear K+, or indirectly interact with heterochromatin, both factors known to affect gene expression.